Quantification of serotonin transporter availability with [ 11C]MADAM - A comparison between the ECAT HRRT and HR systems

NeuroImage

Volumn 60, Issue 1, 2012, Pages 800-807

  Schain, Martin ^a,b   Tóth, Miklós ^a   Cselényi, Zsolt ^a,c   Stenkrona, Per ^a   Halldin, Christer ^a,b   Farde, Lars ^a,c   Varrone, Andrea ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Stockholm Brain Institutet   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

5 HTT; 11C MADAM; HRRT; PET; PVE correction

Indexed keywords

CARBON N,N DIMETHYL 2 (2 AMINO 4 METHYLPHENYLTHIO)BENZYLAMIN C 11; RADIOLIGAND; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; BRAIN TOMOGRAPHY; CAUDATE NUCLEUS; CEREBELLUM; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGING SYSTEM; INSULA; INTERMETHOD COMPARISON; LIGAND BINDING; LIMBIC CORTEX; MALE; NEOCORTEX; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; TEMPORAL CORTEX; THALAMUS;

ADULT; BENZYLAMINES; BRAIN; CARBON RADIOISOTOPES; HUMANS; MALE; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 84856140905     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.12.047     Document Type: Article

References (27)

1. Backstrom I., Bergstrom M., Marcusson J. High affinity [3H] paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res. 1989, 486:261-268.
2. Bergstrom M., Boethius J., Eriksson L., Greitz T., Ribbe T., Widen L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J. Comput. Assist. Tomogr. 1981, 5:136-141.
3. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157:115-118.
4. Campbell M.J., Walters S.J., Machin D. Medical statistics: a textbook for the health sciences 2007, Wiley, Chichester, England; Hoboken, NJ. 4th ed.
5. Chalon S., Tarkiainen J., Garreau L., Hall H., Emond P., Vercouillie J., Farde L., Dasse P., Varnas K., Besnard J.C., Halldin C., Guilloteau D. Pharmacological characterization of N, N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity. J. Pharmacol. Exp. Ther. 2003, 304:81-87.
6. Comtat C., Sureau F.C., Sibomana M., Hong I.K., Sjoholm N., Trebossen R. Image based resolution modeling for the HRRT OSEM reconstructions software. 2008 Ieee Nuclear Science Symposium and Medical Imaging Conference 2009, 3395-3398. Ieee.
7. Cselenyi Z., Olsson H., Halldin C., Gulyas B., Farde L. A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635. NeuroImage 2006, 32:1690-1708.
8. Cunningham V.J., Hume S.P., Price G.R., Ahier R.G., Cremer J.E., Jones A.K. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J. Cereb. Blood Flow Metab. 1991, 11:1-9.
9. de Jong H.W., van Velden F.H., Kloet R.W., Buijs F.L., Boellaard R., Lammertsma A.A. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys. Med. Biol. 2007, 52:1505-1526.
10. Ebdrup B.H., Glenthoj B., Rasmussen H., Aggernaes B., Langkilde A.R., Paulson O.B., Lublin H., Skimminge A., Baare W. Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J. Psychiatry Neurosci. 2009, 35:95-104.
11. Farde L., Eriksson L., Blomquist G., Halldin C. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET-a comparison to the equilibrium analysis. J. Cereb. Blood Flow Metab. 1989, 9:696-708.
12. Geworski L., Knoop B.O., de Cabrejas M.L., Knapp W.H., Munz D.L. Recovery correction for quantitation in emission tomography: a feasibility study. Eur. J. Nucl. Med. 2000, 27:161-169.
13. Halldin C., Swahn C.L.F., Sedvall G. Radioligand disposition and metabolism - key information in early drug development. PET for Drug Development and Evaluation 1995, 55-56. Kluwer Academic Publisher, Dordrecht. D. Comar (Ed.).
14. Halldin C., Lundberg J., Sovago J., Gulyas B., Guilloteau D., Vercouillie J., Emond P., Chalon S., Tarkiainen J., Hiltunen J., Farde L. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET. Synapse 2005, 58:173-183.
15. Larsen A.K., Brennum L.T., Egebjerg J., Sanchez C., Halldin C., Andersen P.H. Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects. Br. J. Pharmacol. 2004, 141:1015-1023.
16. Laruelle M., Vanisberg M.A., Maloteaux J.M. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biol. Psychiatry 1988, 24:299-309.
17. Leroy C., Comtat C., Trebossen R., Syrota A., Martinot J.L., Ribeiro M.J. Assessment of 11C-PE2I binding to the neuronal dopamine transporter in humans with the high-spatial-resolution PET scanner HRRT. J. Nucl. Med. 2007, 48:538-546.
18. Lundberg J., Odano I., Olsson H., Halldin C., Farde L. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. J. Nucl. Med. 2005, 46:1505-1515.
19. Meltzer C.C., Leal J.P., Mayberg H.S., Wagner H.N., Frost J.J. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J. Comput. Assist. Tomogr. 1990, 14:561-570.
20. Meltzer C.C., Kinahan P.E., Greer P.J., Nichols T.E., Comtat C., Cantwell M.N., Lin M.P., Price J.C. Comparative evaluation of MR-based partial-volume correction schemes for PET. J. Nucl. Med. 1999, 40:2053-2065.
21. Mourik J.E., Lubberink M., van Velden F.H., Kloet R.W., van Berckel B.N., Lammertsma A.A., Boellaard R. In vivo validation of reconstruction-based resolution recovery for human brain studies. J. Cereb. Blood Flow Metab. 2009, 30:381-389.
22. Müller-Gärtner H.W., Links J.M., Prince J.L., Bryan R.N., McVeigh E., Leal J.P., Davatzikos C., Frost J.J. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J. Cereb. Blood Flow Metab. 1992, 12:571-583.
23. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3908-3913.
24. Sureau F.C., Reader A.J., Comtat C., Leroy C., Ribeiro M.J., Buvat I., Trebossen R. Impact of image-space resolution modeling for studies with the high-resolution research tomograph. J. Nucl. Med. 2008, 49:1000-1008.
25. van Velden F.H., Kloet R.W., van Berckel B.N., Buijs F.L., Luurtsema G., Lammertsma A.A., Boellaard R. HRRT versus HR+ human brain PET studies: an interscanner test-retest study. J. Nucl. Med. 2009, 50:693-702.
26. Varrone A., Sjoholm N., Eriksson L., Gulyas B., Halldin C., Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:1639-1650.
27. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J. Comput. Assist. Tomogr. 1994, 18:110-118.